Loading [MathJax]/jax/output/HTML-CSS/fonts/TeX/fontdata.js

Journal List > Clin Exp Otorhinolaryngol > v.10(4) > 1157667

TOOLS
Lee and Park: Relationships Among Factors Relevant to Abdominal Fat and Age-Related Hearing Loss
Original Article

Clin Exp Otorhinolaryngol 2017;10(4):309-314.

Published online: 11 May 2017

DOI: https://doi.org/10.21053/ceo.2017.00017

Relationships Among Factors Relevant to Abdominal Fat and Age-Related Hearing Loss

Young Lee1, Mina Park1, 2

1Department of Otorhinolaryngology-Head and Neck Surgery, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea

2Department of Translational Biomedical Research, Seoul National University College of Medicine, Seoul, Korea

Corresponding author: Mina Park Department of Otorhinolaryngology-Head and Neck Surgery, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, 152 Teheran-ro, Gangnam-gu, Seoul 06236, Korea Tel: +82-2-2112-5671, Fax: +82-2-2112-5794 E-mail: pimpleboy@naver.com

Received 31 December 2016       Revised 24 March 2017       Accepted 13 April 2017

Copyright © 2017 by Korean Society of Otorhinolaryngology-Head and Neck Surgery

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Objectives

Metabolic syndrome is related with abdominal fat and with age-related hearing loss (ARHL). In this study, we evaluated the association between a variety of factors relevant to abdominal fat (FRAs) and hearing thresholds.

Methods

We reviewed retrospectively the medical records of 2,602 subjects aged over 40 years with symmetrical sensorineural hearing loss who underwent abdominal fat computed tomography (CT) scans. Univariate and multivariate linear regression analyses were used to demonstrate the association between each FRA and hearing thresholds at low and high frequencies.

Results

Four of 5 FRAs were associated with hearing thresholds at high frequencies in males. All FRAs examined showed a relationship with hearing thresholds at low frequencies in females. Diabetes mellitus (DM) among clinical factors and visceral adipose tissue (VAT) among the 5 FRAs were the most reflective of hearing thresholds in both males and females.

Conclusion

We found that FRAs were associated with hearing loss with frequency specific characteristics according to sex and reinforced that DM and VAT is particularly an important role for hearing.

Go to : Goto

Keywords: Hearing Loss, Abdominal Fat, Visceral Fat, Body Mass Index

INTRODUCTION

Age-related hearing loss (ARHL), also known as presbycusis, is the result of the cumulative effects of aging on hearing. It is characterized by progressive, bilateral, symmetrical sensorineural hearing loss, and results from degeneration of the inner ear (the cochlea) or the auditory nerves. It is the second most common disease, following arthritis, affecting 1 in 3 people ≥65 years, and 1 in 2 people ≥75 years [1]. Moreover, the proportion of the population ≥65 years will continue to increase gradually, and will represent one-quarter of the total population by 2030 [2]. Thus, ARHL is expected to become a major public health issue in future decades.
Obesity is a primary preventable cause of morbidity and mortality and is on the rise worldwide. Body mass index (BMI) has been widely used to define and classify obesity according to World Health Organization criteria [3]. However, abdominal obesity has been regarded as a more important risk factor than BMI [4]. Abdominal obesity consists of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT), the characteristics of which differ in several respects.
Weight, BMI, waist circumference (WC), total adipose tissue (TAT), VAT, and SAT corresponds to factors relevant to abdominal fat (FRAs). Most previous studies that have reported a relationship between obesity and hearing have assessed only 1 of above 6 FRAs, such as BMI [5,6], WC [7], or VAT [8]. To our knowledge, there is only one report showing a relationship between several FRAs and hearing [8]. However, in that study, the sample consisted of 662 adults, which was not sufficient to draw concrete conclusions.
In this study, we sought to evaluate the relationship between several FRAs and hearing thresholds in a larger sample of adults, aged over 40 years. Moreover, we evaluated which factor among the FRAs was most associated with hearing threshold.
Go to : Goto

MATERIALS AND METHODS

Subjects

Between May 2004 and December 2015, 2,602 subjects ≥40 years (range, 40 to 89 years) of age who attended the Seoul National University Hospital Healthcare System at the Gangnam Center underwent fat measurements by computed tomography (CT), pure tone audiometry for 4 frequencies (0.5, 1, 2, and 4 kHz), and examination of the tympanic membrane by otologists. All subjects answered a medical questionnaire and underwent a medical examination. Subjects (n=31) who underwent external or middle ear surgery and/or showed abnormal tympanic membrane findings were excluded; in total, 2,571 subjects (range, 40 to 89 years) were included in the analysis.
This retrospective study was conducted after approval by the Institutional Review Board of the Clinical Research Institute of Seoul National University Hospital (No. 1512-094-728).

Anthropometric measurements

Each subject’s height, weight, and WC were measured after overnight fasting. BMI was calculated by dividing body weight in kilograms by squared height in meters (kg/m2). WC was measured at the level of the mid-point between the inferior border of the ribs and the upper margin of the iliac crest [4].

Measuring the area of abdominal adipose tissue by computed tomography

We used a standard technique to measure abdominal adipose tissue, as described previously [9,10]. Briefly, subjects were scanned in a supine position using a 16-detector CT scanner (Somatom Sensation 16, Siemens AG, Erlangen, Germany). A slice image at the level of the umbilicus, 5 mm in thickness was used to calculate the abdominal adipose tissue. Using Rapidia 2.8 CT software (Infinitt, Seoul, Korea), the surface area that came within –250 to –50 Hounsfield units was deemed to be abdominal adipose tissue. The TAT and VAT were demarcated by manual tracing with a cursor and the difference between TAT and VAT was deemed to be SAT. This was performed by 2 researchers affiliated to Seoul National University Hospital Healthcare System at the Gangnam Center and the mean of 2 values was used for analysis.

Measuring hearing thresholds

Hearing thresholds were measured at 4 frequencies (0.5, 1, 2, and 4 kHz) in both ears for each subject in a double-walled sound booth using audiometry (Madsen Itera II, GN Otometrics, Taastrup, Denmark). The average of the thresholds at 0.5 and 1 kHz was regarded as pure tone audiometry (PTA)-low, and the average at 2 and 4 kHz was regarded as PTA-high.

Classification of the variables

Weight, BMI, WC, TAT, VAT, and SAT were categorized as FRAs. The other factors–age, sex, height, hypertension (HTN), diabetes mellitus (DM), smoking, and alcohol consumption–were categorized as clinical factors.

Statistical analyses

Continuous variables are presented as means±standard deviations (SDs). Categorical variables are presented as frequencies and percentages. Student t-test for continuous variables and chi-square tests for categorical variables were used to compare differences between sexes. We conducted univariate linear regression to identify clinical factors associated with PTA thresholds. The significant clinical factors in univariate analyses and one of the FRAs were then considered as independent variables in a multiple linear regression. A step-wise multiple linear regression analysis was performed to determine the relationships between risk factors and PTA thresholds. The statistical significance level was set at 0.05. ‘R’ software ver. 3.2.2 (R Foundation for Statistical Computing, Vienna, Austria; http://www.R-project.org) was used for statistical analyses.
Go to : Goto

RESULTS

Demographic and anthropometric characteristics

Subject characteristics are summarized in Table 1. In total, 2,571 subjects (n=1,435 males and n=1,136 females) were included in the final analysis. The mean age was 57.6±7.3 years (males, 57.5±7.6 years; females, 57.8±7.0 years) with no significant difference. The mean height, weight, BMI, and WC were 165.0±8.3 cm, 65.1±11.9 kg, 23.8±3.2 kg/m2, and 85.2±9.0 cm, respectively, with significant differences between males and females (height, 170.5±5.8 cm vs. 158.0±5.2 cm; weight, 71.6±10.0 kg vs. 57.0±8.7 kg; BMI, 24.6±2.9 kg/m2 vs. 22.8±3.2 kg/m2; and WC, 88.5±7.9 cm vs. 81.2±8.6 cm; all P<0.001). For all subjects, the mean PTA-low and PTA-high hearing levels were 16.7±8.3 dB HL and 23.4±13.2 dB HL, respectively. The PTA-low hearing level did not differ between the sexes. However, females had a significantly lower PTA-high hearing level (26.3±14.1 dB HL vs. 19.7±11.0 dB HL, P<0.001). VAT was significantly higher in males than in females and SAT was higher in females than in males (P<0.001). Total adipose tissue showed no significant difference between males and females. The incidences of HTN and DM were higher in males than in females (P<0.001), and the incidences of smoking and alcohol consumption were higher in males than in females (P<0.001).
Table 1.
Comparisons between male and female subjects regarding to demographic, auditory, and factors relevant abdominal fat
Variable All (n=2,571) Male (n=1,435) Female (n=1,136) P-value
Age (yr) 57.6±7.3 57.5±7.6 57.8±7.0 0.234
Height (cm) 165.0±8.3 170.5±5.8 158.0±5.2 <0.001
Weight (kg) 65.1±11.9 71.6±10.0 57.0±8.7 <0.001
BMI (kg/m2) 23.8±3.2 24.6±2.9 22.8±3.2 <0.001
WC (cm) 85.2±9.0 88.5±7.9 81.2±8.6 <0.001
PTA-low (dB HL) 16.7±8.3 16.8±8.4 16.6±8.2 0.435
PTA-high (dB HL) 23.4±13.2 26.3±14.1 19.7±11.0 <0.001
TAT (cm2) 292.0±161.1 290.0±125.4 294.5±197.2 0.504
VAT (cm2) 122.7±70.4 144.4±65.2 95.3±67.2 <0.001
SAT (cm2) 169.3±116.8 145.6±71.8 199.3±150.9 <0.001
HTN <0.001
 No 1,065 (77.9) 614 (74.2) 451 (83.5)
 Yes 303 (22.1) 214 (25.8) 89 (16.5)
DM 0.007
 No 1,256 (91.9) 746 (90.2) 510 (94.4)
 Yes 111 (8.1) 81 (9.8) 30 (5.6)
Smoking <0.001
 No 854 (82.3) 523 (75.4) 331 (96.2)
 Yes 184 (17.7) 171 (24.6) 13 (3.8)
Alcohol <0.001
 No 267 (18.5) 65 (7.4) 202 (36.1)
 Yes 1,176 (81.5) 818 (92.6) 358 (63.9)

Values are presented as number (%) or mean±standard deviation.

BMI, body mass index; WC, waist circumference; PTA-low, hearing thresholds at low frequencies; PTA-high, hearing thresholds at high frequencies; TAT, total adipose tissue; VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue; HTN, hypertension; DM, diabetes mellitus.

Download Table

Relationship between hearing threshold, clinical factors, and FRAs

Univariate analysis

VAT and SAT was significantly different between sexes (Table 1). This means that sex played a part when hearing and FRAs were analyzed by regression analysis. For this reason, we reanalyzed this relationship with every regard to sex.
Regarding PTA-low, univariate analysis showed that age, height, BMI, WC, VAT, HTN, DM, and alcohol consumption correlated with hearing regardless of sex; weight correlated with hearing only in male. Regarding PTA-high, age, height, weight, BMI, WC, VAT, HTN, and DM correlated with hearing regardless of sex; alcohol consumption correlated with hearing in female and male (Table 2).
Table 2.
Univariate analysis for hearing by several variables
Variable PTA-low
 PTA-high
All
 Male
 Female
 All
 Male
 Female
β±SE P-value β±SE P-value β±SE P-value β±SE P-value β±SE P-value β±SE P-value
Age 0.385±0.021 <0.001 0.34±0.028 <0.001 0.454±0.032 <0.001 0.713±0.033 <0.001 0.758±0.045 <0.001 0.672±0.042 <0.001
Sex 0.258±0.330 0.435 - - - - 6.591±0.510 <0.001 - - - -
Height –0.104±0.020 <0.001 –0.226±0.038 <0.001 –0.313±0.046 <0.001 0.135±0.031 <0.001 –0.362±0.064 <0.001 –0.332±0.062 <0.001
Weight –0.017±0.014 0.223 –0.083±0.022 <0.001 0.040±0.028 0.149 0.127±0.022 <0.001 –0.115±0.037 0.002 0.029±0.038 0.440
BMI 0.133±0.052 0.011 –0.09±0.078 0.249 0.348±0.075 <0.001 0.415±0.083 <0.001 –0.006±0.131 0.648 0.331±0.101 0.001
WC 0.082±0.018 <0.001 0.020±0.028 0.473 0.166±0.028 <0.001 0.236±0.029 <0.001 0.035±0.048 0.456 0.180±0.038 <0.001
TAT 0.002±0.001 0.069 –0.001±0.002 0.598 0.003±0.001 0.008 0.001±0.002 0.373 –0.002±0.003 0.510 0.004±0.002 0.030
VAT 0.007±0.002 0.003 –0.001±0.003 0.847 0.016±0.004 <0.001 0.024±0.004 <0.001 0.003±0.006 0.652 0.018±0.005 <0.001
SAT 0.001±0.001 0.467 –0.002±0.003 0.456 0.002±0.002 0.140 –0.006±0.002 0.006 –0.008±0.005 0.119 0.003±0.002 0.218
HTN 1.860±0.566 0.001 1.373±0.691 0.047 2.962±1.005 0.003 2.278±0.889 0.010 0.418±1.131 0.712 3.871±1.374 0.005
DM 2.579±0.861 0.003 1.937±1.019 0.058 4.275±1.630 0.009 5.765±1.347 <0.001 4.298±1.660 0.010 6.733±2.223 0.003
Smoking 0.204±0.702 0.771 0.036±0.777 0.964 0.413±2.333 0.860 1.116±1.111 0.316 –1.195±1.260 0.343 1.481±3.162 0.640
Alcohol –2.070±0.591 <0.001 –1.653±1.120 0.140 –2.628±0.772 <0.001 –0.974±0.928 0.294 –6.827±1.821 <0.001 –2.901±1.046 0.006

For both PTA-low and PTA-high, age, BMI, WC, VAT, HTN, and DM were correlated with hearing regardless of sex.

PTA-low, hearing thresholds at low frequencies; PTA-high, hearing thresholds at high frequencies; SE, standard error; BMI, body mass index; WC, waist circumference; TAT, total adipose tissue; VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue; HTN, hypertension; DM, diabetes mellitus.

Download Table

Multivariate analysis

All factors were included in a multivariate analysis, apart from SAT and smoking, which did not show a statistically significant difference between females and males. The 5 clinical factors (age, height, HTN, DM, and alcohol consumption) and each of the FRAs (weight, BMI, WC, TAT, and VAT) were analyzed 5 times independently. That is, 6 factors, 5 clinical factors plus one FRA, were analyzed 5 times, independently.
For males, while no factor among the FRAs showed a significant difference in any analysis in PTA-low, all factors except TAT showed significant differences in PTA-high (Table 3). For females, while all FRAs showed significant differences in PTA-low, 3 of 5 factors (weight, BMI, and WC) showed no significant difference in PTA-high (Table 4).
Table 3.
Multivariate analyses for hearing thresholds at low and high frequencies by clinical factors inclusive of each factor relevant to obesity in males
Independent variable PTA-low
 PTA-high
β±SE P-value Model R2 β±SE P-value Model R2
Age, height, HTN, DM, alcohol, weight 0.111 0.176
 Age 0.338±0.047 <0.001 0.734±0.074 <0.001
 Height –0.188±0.061 0.002 –0.287±0.109 0.009
 HTN - - –1.921±1.226 0.118
 DM 1.713±1.085 0.115 4.068±1.755 0.021
 Alcohol - - –5.307±2.122 0.013
 Weight - - 0.108±0.065 0.099
Age, height, HTN, DM, alcohol, BMI 0.111 0.176
 Age 0.338±0.047 <0.001 0.735±0.074 <0.001
 Height –0.188±0.061 0.002 –0.196±0.096 0.040
 HTN - - –1.922±1.226 0.117
 DM 1.713±1.085 0.115 4.065±1.755 0.021
 Alcohol - - –5.316±2.122 0.012
 BMI - - 0.326±0.193 0.092
Age, height, HTN, DM, alcohol, WC - -
 Age 0.338±0.047 <0.001 0.717±0.073 <0.001
 Height –0.188±0.061 0.002 –0.228±0.097 0.020
 HTN - - –1.908±1.227 0.120
 DM 1.713±1.085 0.115 4.063±1.756 0.021
 Alcohol - - –5.319±2.123 0.012
 WC - - 0.113±0.073 0.125
Age, height, HTN, DM, alcohol, TAT 0.111 0.173
 Age 0.338±0.047 <0.001 0.705±0.073 <0.001
 Height –0.188±0.061 0.002 –0.199±0.096 0.039
 HTN - - - -
 DM 1.713±1.085 0.115 3.460±1.697 0.042
 Alcohol - - –5.369±2.126 0.012
 TAT - - - -
Age, height, HTN, DM, alcohol, VAT 0.111 0.177
 Age 0.338±0.047 <0.001 0.711±0.073 <0.001
 Height –0.188±0.061 0.002 –0.209±0.096 0.029
 HTN - - –1.946±1.225 0.113
 DM 1.713±1.085 0.115 4.025±1.754 0.022
 Alcohol - - –5.381±2.121 0.011
 VAT - - 0.018±0.010 0.061

Any among the factors relevant to abdominal fat was not correlated with PTA-low, meanwhile, all factors except TAT were significantly correlated with PTA-high.

PTA-low, hearing thresholds at low frequencies; PTA-high, hearing thresholds at high frequencies; SE, standard error; HTN, hypertension; DM, diabetes mellitus; BMI, body mass index; WC, waist circumference; TAT, total adipose tissue; VAT, visceral adipose tissue.

Download Table

Table 4.
Multivariate analyses for hearing by several factors including factors relevant to obesity in females
Independent variable PTA-low
 PTA-high
β±SE P-value Model R2 β±SE P-value Model R2
Age, height, HTN, DM, alcohol, Weight 0.278 0.260
 Age 0.484±0.062 <0.001 0.806±0.082 <0.001
 Height –0.279±0.084 0.001 - -
 HTN - - - -
 DM 4.166±1.701 0.015 5.340±2.358 0.024
 Alcohol - - - -
 Weight 0.125±0.057 0.029 - -
Age, height, HTN, DM, alcohol, BMI 0.278 0.260
 Age 0.484±0.062 <0.001 0.806±0.082 <0.001
 Height 0.312±0.142 0.029 - -
 HTN - - - -
 DM 4.171±1.700 0.015 5.340±2.358 0.024
 Alcohol - - - -
 BMI 0.312±0.142 0.029 - -
Age, height, HTN, DM, alcohol, WC 0.281 0.260
 Age 0.464±0.063 <0.001 0.806±0.082 <0.001
 Height –0.228±0.079 0.004 - -
 HTN - - - -
 DM 4.068±1.698 0.017 5.340±2.358 0.024
 Alcohol - - - -
 WC 0.130±0.053 0.014 - -
Age, height, HTN, DM, alcohol, TAT 0.282 0.263
 Age 0.481±0.062 <0.001 0.791±0.082 <0.001
 Height –0.218±0.079 0.006 - -
 HTN - - - -
 DM 4.614±1.670 0.006 5.145±2.358 0.030
 Alcohol - - - -
 TAT 0.006±0.002 0.011 0.005±0.003 0.139
Age, height, HTN, DM, alcohol, VAT 0.284 0.266
 Age 0.471±0.062 <0.001 0.780±0.083 <0.001
 Height –0.219±0.079 0.006 4.831±2.365 0.042
 HTN - - - -
 DM 4.317±1.675 0.010 4.831±2.365 0.042
 Alcohol - - - -
 VAT 0.015±0.006 0.006 0.014±0.008 0.064

All factors relevant to abdominal fat were significantly related with PTA-low, meanwhile, 3 of 5 factors were not related with PTA-high.

PTA-low, hearing thresholds at low frequencies; PTA-high, hearing thresholds at high frequencies; SE, standard error; HTN, hypertension; DM, diabetes mellitus; BMI, body mass index; WC, waist circumference; TAT, total adipose tissue; VAT, visceral adipose tissue.

Download Table

Among the clinical factors, DM showed significant differences regardless of sexes and hearing thresholds in low/high frequency. The values of R2 were highest when VAT was included among the FRAs in multivariate analyses in PTA high and PTA low for both males and females (R2=0.177 and 0.284, respectively).
Go to : Goto

DISCUSSION

In this study, we showed that the FRAs were correlated with hearing at high frequencies in males, whereas FRAs were correlated with hearing at low frequencies for females. Although there was not a big difference, VAT among the FRAs best described PTA-high and PTA-low for both males and females. To our knowledge, this is the first study to assess the relationship between a variety of FRAs including VAT and hearing thresholds.
The mechanisms interlinking FRAs and ARHL have not been documented clearly. Abdominal fat increase the risk of the type 2 DM and dyslipidemia. Regarding to type 2 DM, it was shown to cause hearing loss due to angiopathy, neuropathy, and oxidative stress and remnants of glycation end products [11]. Regarding to dyslipidemia, it was shown to causes swelling of the strial marginal layer and the outer hair cell in guinea pigs [12]. Therefore, we presume that the mechanism interlinking FRAs and ARHL might include a complicated relevance, comprising angiopathy, imbalance of redox, and neuropathy following to metabolic remnants of abdominal obesity. This gives explanations in part, it is still not clear if abdominal obesity could induce to ARHL.
It is unclear why the association between FRAs and ARHL differed between men and women. However, we suggest that the difference may be due to sex-related differences in the distributions of adipocytokines, hormones, and adipose tissue. Adiponectin is an adipocytokine released from adipose tissue and has a protective effect against atherogenic and inflammatory issues [13]. Concentrations of adiponectin are higher in females than in males [14]. Moreover, estrogen has been found to have a protective effect in the maintenance of the auditory system in females [15,16]. Finally, VAT is higher in males than females, whereas SAT is higher in females than males [17].
Our result that VAT played a role in hearing regardless of sex is consistent with previous studies showing that VAT is more involved in metabolic disease than is SAT [17-19]. VAT differs from SAT in several respects. First, VAT exists primarily in the mesentery/omentum and passes via the portal circulation to the liver. Second, VAT contains more glucocorticoid/androgen receptors and a greater number of inflammatory/immune cells. Third, VAT is more active in metabolism and more sensitive to lipolysis. Finally, VAT has a greater ability to take up glucose and to release free fatty acids [18].
Early intervention studies demonstrated that physical activity was helpful in reducing visceral adipose fat [20-22]. Haas et al. [23] showed that physical activity correlated with better hearing. Our study might suggest a link between these studies, given that we propose an effect of VAT on hearing.
This study has several limitations. First, this was a cross-sectional study, so we can only interpret the phenomenon, not reveal its pathophysiology. Second, the values of R2 were similar between the analyses, and the explanatory capacity for hearing might be altered with other study samples. Third, the thresholds at extremely low (0.25 kHz) and high frequencies (8 and 16 kHz) were not assessed. The hearing thresholds were tested at 4 frequencies, 0.5, 1, 2, and 4 kHz, used in routine health checkups.
Our study provides further evidence that FRA is associated with ARHL in males for high frequencies and in females for low frequencies in adults aged over 40 years, and that DM and VAT in particular has major implications for hearing. Further study addressing whether weight loss with a decrease in abdominal fat would slow progression of hearing loss might be interesting.
Go to : Goto

HIGHLIGHTS

▪ Factors relevant abdominal fat (FRAs) were correlated with hearing at high frequencies in men.
▪ In women, FRAs were correlated with hearing at low frequencies.
▪ Visceral adipose tissue has major implications for hearing.
Go to : Goto

Notes

No potential conflict of interest relevant to this article was reported.

Go to : Goto

REFERENCES

1. Presbycusis [Internet]. Wikimedia Foundation, Inc.;c2016. [cited 2016 Jul 15]. Available from: https://en.wikipedia.org/wiki/Presbycusis.
2. Statistics Korea. Population projections for Korea: 2010-2060 (based on the 2010 census) [Internet]. Daejeon, Korea: Statistics Korea;2011. [cited 2016 Jul 15]. Available from: http://kostat.go.kr/portal/korea/kor_nw/2/2/6/index.board?bmode=list&bSeq=&aSeq=&pageNo=2&rowNum=10&navCount=10&currPg=&sTarget=title&sTxt=.
3. World Health Organization Western Pacific Region. The Asia-Pacific perspective: redefining obesity and its treatment. Melbourne, Australia: International Association for the Study of Obesity;2000.
4. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: a new world-wide definition: a consensus statement from the International Diabetes Federation. Diabet Med. 2006; May. 23(5):469–80.
5. Kim SH, Won YS, Kim MG, Baek YJ, Oh IH, Yeo SG. Relationship between obesity and hearing loss. Acta Otolaryngol. 2016; Oct. 136(10):1046–50.
crossref
6. Jung DJ, Jang JH, Lee KY. Is body mass index associated with the development of age-related hearing impairment in Koreans? The Korean national health and nutrition examination survey 2009-2012. Clin Exp Otorhinolaryngol. 2016; Jun. 9(2):123–30.
crossref
7. Hwang JH, Wu CC, Hsu CJ, Liu TC, Yang WS. Association of central obesity with the severity and audiometric configurations of age-related hearing impairment. Obesity (Silver Spring). 2009; Sep. 17(9):1796–801.
crossref
8. Kim TS, Park SW, Kim DY, Kim EB, Chung JW, So HS. Visceral adipose tissue is significantly associated with hearing thresholds in adult women. Clin Endocrinol (Oxf). 2014; Mar. 80(3):368–75.
crossref
9. Goodpaster BH. Measuring body fat distribution and content in humans. Curr Opin Clin Nutr Metab Care. 2002; Sep. 5(5):481–7.
crossref
10. Chung SJ, Kim D, Park MJ, Kim YS, Kim JS, Jung HC, et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut. 2008; Oct. 57(10):1360–5.
crossref
11. Maia CA, Campos CA. Diabetes mellitus as etiological factor of hearing loss. Braz J Otorhinolaryngol. 2005; Mar-Apr. 71(2):208–14.
crossref
12. Satar B, Ozkaptan Y, Surucu HS, Ozturk H. Ultrastructural effects of hypercholesterolemia on the cochlea. Otol Neurotol. 2001; Nov. 22(6):786–9.
crossref
13. Lu JY, Huang KC, Chang LC, Huang YS, Chi YC, Su TC, et al. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond. J Biomed Sci. 2008; Sep. 15(5):565–76.
crossref
14. Hwang JH, Hsu CJ, Liu TC, Yang WS. Association of plasma adiponectin levels with hearing thresholds in adults. Clin Endocrinol (Oxf). 2011; Nov. 75(5):614–20.
crossref
15. Hederstierna C, Hultcrantz M, Collins A, Rosenhall U. Hearing in women at menopause: prevalence of hearing loss, audiometric configuration and relation to hormone replacement therapy. Acta Otolaryngol. 2007; Feb. 127(2):149–55.
crossref
16. Hwang JH, Chao JC, Ho HC, Hsiao SH. Effects of sex, age and hearing asymmetry on the interaural differences of auditory brainstem responses. Audiol Neurootol. 2008; 13(1):29–33.
crossref
17. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007; Jul. 116(1):39–48.
18. Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010; Jan. 11(1):11–8.
crossref
19. Tanko LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation. 2003; Apr. 107(12):1626–31.
crossref
20. Vissers D, Hens W, Taeymans J, Baeyens JP, Poortmans J, Van Gaal L. The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS One. 2013; 8(2):e56415.
crossref
21. Janiszewski PM, Ross R. Physical activity in the treatment of obesity: beyond body weight reduction. Appl Physiol Nutr Metab. 2007; Jun. 32(3):512–22.
crossref
22. Ohkawara K, Tanaka S, Miyachi M, Ishikawa-Takata K, Tabata I. A dose-response relation between aerobic exercise and visceral fat reduction: systematic review of clinical trials. Int J Obes (Lond). 2007; Dec. 31(12):1786–97.
crossref
23. Haas PJ, Bishop CE, Gao Y, Griswold ME, Schweinfurth JM. Relationships among measures of physical activity and hearing in African Americans: the Jackson Heart Study. Laryngoscope. 2016; Oct. 126(10):2376–81.
crossref
Go to : Goto

TOOLS
Similar articles